DEF: Alignment Healthcare Achieves First Full Year of Adjusted EBITDA Profitability, Reports Strong Membership and Revenue Growth
Proxy Statement
Alignment Healthcare reports a milestone year in 2024, achieving its first full year of positive adjusted EBITDA, industry-leading membership growth, and strong revenue growth.
Summary
- Alignment Healthcare had a milestone year in 2024, achieving its first full year of positive adjusted EBITDA as a public company.
- The company achieved adjusted EBITDA of $1 million.
- Membership grew by 59% year-over-year to 189,100 members as of December 31, 2024.
- Revenue reached $2.7 billion, representing 48% growth year-over-year as of December 31, 2024.
- 98% of members are in plans that earned 4 Stars or better under the CMS 5-Star Quality Rating System, compared to the industry average of 64%.
- The company's HMO contract in Nevada and North Carolina earned a 5-Star rating.
- The company achieved an overall Net Promoter Score (NPS) of 61, including an NPS of greater than 78 for the Care Anywhere program.
- The company achieved a 4.9 out of 5-star Google rating, based on more than 9,000 reviews.
- The medical benefits ratio (MBR) was 88.8% in 2024 based on adjusted gross profit.
- In 2025, the company is focused on sustained growth, improving profitability, greater replicability, and continuous improvement.
Sentiment
Score: 8
Explanation: The document presents a positive outlook with strong financial results and growth metrics, indicating a favorable sentiment.
Positives
- The company achieved adjusted EBITDA profitability for the first time as a public company.
- The company experienced industry-leading membership growth.
- The company experienced strong revenue growth.
- The company achieved exceptional quality ratings.
- The company achieved outstanding member service ratings.
- The company demonstrated strong medical cost management.
Risks
- The company's ability to attract new members and enter new markets is subject to governmental approvals.
- The company's ability to maintain a high rating for its plans on the CMS Five Star Quality Rating System is crucial.
- The company's ability to develop and maintain satisfactory relationships with care providers is important.
- Changes in laws and regulations applicable to the company's business model could impact performance.
- Risks related to the company's indebtedness could affect financial stability.
- Changes in market or industry conditions and receptivity to the company's technology and services could pose challenges.
- Results of litigation or a security incident could negatively impact the company.
- Shortages of qualified personnel and related increases in labor costs could affect profitability.
Future Outlook
In 2025, the company is focused on sustained growth, improving profitability, greater replicability, and continuous improvement, with a goal to provide the best care at the lowest cost.
Management Comments
- By approaching MA as a care management business and focusing on serving our seniors, we are proving that we can win by delivering more care not less.
- Our continued ability to capture market share reflects our reputation for consistent delivery of quality care, innovative products and enhanced benefits.
- Our goal is to always ensure we provide the best care at the lowest cost.
- We aim to further improve profitability of the enterprise by retaining the members we grew in 2024 and engaging those most at risk with our clinical model.
- We plan to increase productivity and improve scalability by deploying tools that drive more automation.
- We aim to deliver consistently high-quality care across markets.
- As we scale, our management team remains focused on disciplined execution, data-driven decision making and an unwavering drive to serve our members better every day.
Industry Context
Alignment Healthcare's focus on quality and value in Medicare Advantage positions it well in a dynamic MA environment, differentiating it from competitors and enabling strong growth.
Comparison to Industry Standards
- Alignment Healthcare's 98% of members in plans with 4 Stars or better significantly exceeds the industry average of 64%.
- Alignment Healthcare is one of only nine MA plans in the entire country in 2025 to earn a coveted 5 Stars in Nevada and North Carolina.
- The company's hospitalization rate of approximately 149 hospitalizations per every 1,000 at-risk members is approximately 41% lower than the 2019 Medicare FFS performance in its markets.
- Comparible companies include Oak Street Health, agilon health, and Privia Health Group.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President | Dawn Maroney (President, Markets) | Dawn Maroney | 2025-01-01 | Expanded role and responsibilities |
Related Party Transactions
- The company is party to an Amended and Restated Stockholders Agreement with General Atlantic.
- The company is party to a registration rights agreement with General Atlantic and certain other stockholders.
- Mr. Konowieckis son is a partner in the law firm of McDermott Will & Emery LLP (MWE), which provided legal services to the Company.
Stakeholder Impact
- The company's performance and strategic initiatives are expected to create long-term value for all stakeholders, including shareholders, employees, customers, suppliers, and creditors.
- The company's focus on improving the health care experience for seniors benefits its members and their families.
- The company's commitment to corporate responsibility and sustainable business practices reflects its consideration of the interests of all stakeholders.
Next Steps
- The company will hold its Annual Meeting of Stockholders on June 5, 2025.
- The company will share updates on its progress throughout upcoming quarterly earnings calls.
- The company will continue to engage with stockholders and other stakeholders throughout the year.
- The company will continue to focus on sustained growth, improving profitability, greater replicability, and continuous improvement in 2025.
Key Dates
| Date | Description |
|---|---|
| 2021-03-30 | Date of the registration rights agreement with the Lead Sponsor and certain other stockholders. |
| 2021-03-26 | Effective date of amended and restated employment agreements with Mr. Kao, Mr. Freeman and Ms. Maroney. |
| 2023-09-25 | Effective date of employment agreement with Dr. Kim. |
| 2024-01-08 | Effective date of employment agreement with Mr. Wagner. |
| 2024-04-30 | Date of the Amended and Restated Stockholders Agreement. |
| 2025-04-07 | Record date for the 2025 Annual Meeting of Stockholders. |
| 2025-04-25 | Approximate date of distribution of proxy materials to stockholders. |
| 2025-06-05 | Date of the 2025 Annual Meeting of Stockholders. |
| 2025-12-26 | Deadline for submitting stockholder proposals for inclusion in the 2026 proxy statement. |
| 2026-03-07 | Latest date for stockholders to provide written notice of a director nomination or proposal for the 2026 annual meeting. |
| 2026-04-06 | Deadline for stockholders to provide notice of intent to solicit proxies in support of director nominees other than the company's nominees. |
Keywords
Medicare Advantage, Adjusted EBITDA, Membership Growth, Revenue Growth, CMS Star Ratings, Net Promoter Score, Medical Benefits Ratio, Executive Compensation, Corporate Governance, Proxy Statement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.